6 DRUG (COP-BLAM) COMBINATION CHEMOTHERAPY OF DIFFUSE HISTIOCYTIC LYMPHOMA

被引：0
|
作者：
LAURENCE, JC [1 ]
BROWER, MS [1 ]
COLEMAN, M [1 ]
PASMANTIER, MW [1 ]
机构：
[1] CORNELL UNIV,NEW YORK HOSP,CTR MED,NEW YORK,NY 10021
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [31] RELAPSE WITH NODULAR LYMPHOMA FOLLOWING COMBINATION CHEMOTHERAPY FOR DIFFUSE NON-HODGKINS-LYMPHOMA
    SIEGEL, RD
    SKARIN, AT
    CANELLOS, GP
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (05): : 420 - 423
  • [32] PROMACE-CYTABOM - COMBINATION CHEMOTHERAPY FOR DIFFUSE LARGE CELL LYMPHOMA
    PROKOCIMER, M
    MODAN, M
    RUSOSHANSKY, S
    BAIREY, O
    SHAKLAI, M
    [J]. ANTICANCER RESEARCH, 1989, 9 (04) : 1233 - 1235
  • [33] A FOLLOW-UP OF A RANDOMIZED STUDY COMPARING 2 CHEMOTHERAPY TREATMENTS FOR ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA
    TODD, M
    CADMAN, E
    SPIRO, P
    BERTINO, J
    FARBER, L
    WALDRON, J
    FISCHER, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (09) : 986 - 993
  • [34] 6 DRUG ALTERNATING COMBINATION CHEMOTHERAPY IN THE TREATMENT OF POOR PROGNOSIS NON-HODGKINS-LYMPHOMA
    GREEN, JA
    [J]. BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 217 - 218
  • [35] COMBINATION CHEMOTHERAPY FOR ADVANCED NON-HODGKINS LYMPHOMAS OTHER THAN DIFFUSE HISTIOCYTIC OR UNDIFFERENTIATED HISTOLOGIES
    ANDERSON, KC
    SKARIN, AT
    ROSENTHAL, DS
    MACINTYRE, JM
    PINKUS, GS
    CASE, DC
    LEONARD, RCF
    CANELLOS, GP
    [J]. CANCER TREATMENT REPORTS, 1984, 68 (11): : 1343 - 1350
  • [36] Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma
    Niitsu, N
    Umeda, M
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 56 (03) : 163 - 167
  • [37] NHL-3 PROTOCOL - 6-DRUG COMBINATION CHEMOTHERAPY FOR NON-HODGKINS LYMPHOMA
    KOZINER, B
    SKLAROFF, R
    LITTLE, C
    LABRIOLA, D
    THALER, HT
    STRAUS, DJ
    YOUNG, CW
    NISCE, LZ
    OETTGEN, H
    LEE, BJ
    CLARKSON, BD
    [J]. CANCER, 1984, 53 (12) : 2592 - 2600
  • [38] COMBINATION (COP) VERSUS SUCCESSIVE SINGLE AGENT CHEMOTHERAPY (C-O-P) IN LYMPHOCYTIC LYMPHOMA
    KENNEDY, BJ
    HILL, J
    BLOOMFIELD, C
    KIANG, D
    FORTUNY, I
    THEOLOGIDES, A
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 142 - 142
  • [39] SUCCESSFUL USE OF COMBINATION CHEMOTHERAPY IN PURE RED-CELL APLASIA ASSOCIATED WITH MALIGNANT LYMPHOMA, HISTIOCYTIC TYPE
    HUNT, FA
    LANDER, CM
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1975, 5 (05): : 469 - 471
  • [40] CONTINUOUS INFUSION VINCRISTINE (V) AS A COMPONENT OF INITIAL CHEMOTHERAPY FOR STAGE III-IV DIFFUSE HISTIOCYTIC LYMPHOMA (DHL)
    CRAIG, J
    JACKSON, D
    POWELL, B
    MCMAHAN, R
    RICHARDS, F
    POPE, E
    MUSS, H
    WHITE, D
    CRUZ, J
    ZEKAN, P
    SPURR, C
    CAPIZZI, R
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 182 - 182
12345